Navigation Links
FDA Clears MDN-CGS(R) Intravenous Insulin Dosing Software
Date:10/18/2007

CHARLOTTESVILLE, Va., Oct. 18 /PRNewswire/ -- Medical Decisions Network (MDN) announces Food and Drug Administration 510(k) clearance for the company's MDN-CGS IV Insulin Dosing Software. The MDN-CGS software is used by hospital nurses to quickly and accurately calculate the dosage of intravenous insulin administered to patients with elevated levels of blood glucose, the simple form of sugar the body converts to energy for survival.

More and more hospitals are adopting measures to control elevated glucose levels (commonly referred to as diabetes or hyperglycemia) in critical care units because studies have shown a resulting marked improvement in patient outcomes. These improvements include reduced mortality (death), length of stay, rate of infection, and a variety of other risks. According to Gary Stouder, MD, at Indiana's Hancock Regional Hospital, "Based on what we've seen so far, by automating our insulin dosing protocol with the MDN-CGS software, we expect to see a decrease in length of stay of 1 day and up to a 50% decrease in mortality in our hyperglycemic ICU patients."

Currently, hospitals rely on printed procedures to calculate IV insulin dosage based on hyperglycemic patients' varying glucose levels. More frequent glucose tests - as many as one or more per hour for tightly controlled ICU patients - burden the already overextended nurses. And referring to complicated paper protocols stresses clinical staff even more. Computerizing these calculations and providing automated patient reports may not only improve glucose control and save critical time and resources, but may reduce potentially dangerous dosing calculation errors as well.

The health benefits of this technology are hard to resist: MDN-CGS users have seen a stark reduction in the incidence of hypoglycemia, a potentially life-threatening severe drop in blood glucose. And it takes significantly less time to get a patient out of the danger zone and into the target glucose range(1).

According to Greg Menke, Medical Decisions Network's CEO, "We've seen technology make sweeping improvements in the quality and cost of healthcare. Our MDN-CGS Computerized Insulin Dosing Software is another major contributor to these improvements because it gives hospital clinicians the power to control hyperglycemia, a huge and growing health and cost burden in this country."

The MDN CGS is a networked application, accessible from any computer on a hospital's network. This means that clinicians can continue a patient's infusion progress even when the patient is moved to a new unit.

"This FDA 510(k) clearance will be important for clinical administrators who are considering the move to this beneficial technology and feel more comfortable with FDA's nod," says Menke. "It's an important step for all of us."

For more information, visit http://www.mdnoutcomes.net.

About Medical Decisions Network

Medical Decisions Network (http://www.mdnoutcomes.net) is an affiliate of Medical Automation Systems, the leader in connectivity solutions for clinical laboratory point-of-care data management, and TEG, Virginia, LLC, an international healthcare research and consulting firm. MDN-CGS is a trademark of Medical Decisions Network.

1. Juneja, Rattan, et al, Utilization of a Computerized Intravenous Insulin Infusion Program to Control Blood Glucose in the Intensive Care Unit. Diabetes Technology & Therapeutics. Jun 2007, Vol. 9, No. 3: 232-240.

Contact: Rick Import

Office: (866) 791-6108 x 1017

E-mail: rimport@mdnoutcomes.net


'/>"/>
SOURCE Medical Decisions Network
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Spray on contraceptive clears Phase I trial
2. Baby Acne Clears Up On Its Own
3. SC Clears Deck For Implementation Of Nutrition Scheme
4. Bangkoks Public Health Ministry Clears The Northern Province Of Bird Flu Epidemic
5. Cabinet Clears Purchase Preference Policy for Pharma PSUs
6. European Commission Clears Diabetic Insulin for Pregnant Women
7. Delhi Government Clears Healthcare Projects Worth Rs.1.13 bn
8. FDA Clears Breast Cancer Specific Molecular Prognostic Test
9. FDA Clears Critical Limb-Saving Vascular Device
10. Japanese Expedition Clears Half Ton of Garbage from Mt. Everest
11. Painkilling Patch As Effective As Intravenous Delivery Systems
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... 2017 , ... The Radiology Business Management Association (RBMA) is pleased ... new executive director. Mr. Still was selected through a careful months-long search by the ... is known to our members, has been a part of building the RBMA since ...
(Date:3/28/2017)... , ... March 28, 2017 , ... With less than ... acne, access to quality care can be limited while the desire to conquer breakouts ... customized prescription acne care for every customer online, today released its inaugural survey on ...
(Date:3/28/2017)... ... March 28, 2017 , ... A minimally invasive porcelain ... smile.” The National Association of Dental Laboratories (NADL) is informing dentists about the ... of when utilizing dental laboratories and technicians that create these veneers. , ...
(Date:3/28/2017)... ... ... With expansion and efficiency in mind, Patten Seed Company completed relocation of ... opened in Marshallville in 2006, and a bagging and shipping facility has been in ... Patten Seed operations to the Middle Georgia location from their previous home in Lakeland, ...
(Date:3/28/2017)... ... ... Prophets Bones”: a thrilling adventure that reveals the mystery of Kevin’s purpose. “A Prophets Bones” ... and teachers had asked of him that he had neglected to do, but this was ... Creator. There were some who would have felt themselves to be special and better than ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... TAIPEI, Taiwan , March 28, 2017 /PRNewswire/ ... medical device company, is pleased to announce ... Series A investment of Panther Orthopedics, Inc., a ... pioneering innovative dynamic fixation solutions for orthopedic extremity ... market continues to expand rapidly, primarily due to ...
(Date:3/27/2017)... , March 27, 2017 ... better understand Eli Lilly and its partnering interests and activities ... 2010 report provides an in-depth insight into the partnering activity ... On demand company reports are prepared upon purchase to ... company data. The report will be delivered in ...
(Date:3/27/2017)... March 27, 2017  Cryoport, Inc. (NASDAQ: CYRX, CYRXW) ... to offer shares of common stock in an underwritten ... file with the Securities and Exchange Commission (the "SEC"). ... and there can be no assurance as to whether ... to the actual size or terms of the offering. ...
Breaking Medicine Technology: